Neurosurgical conditions are often incurable and lead to disability, severe physical symptoms, and distress for patients and families. Neurosurgeons may be responsible for transitioning management from curative to palliative. We sought to analyze the ethics of transitioning care from curative to palliative in patients in one's own specialty.
MethodsThis was a case-based narrative review. PubMed and Google Scholar were searched with no restrictions on date. Studies relevant to the topic were included.
ResultsAfter providing an introductory case, we defined the curative and palliative neurosurgical treatment paradigms, clarified the concept of transition of care from curative to palliative, and contrasted generalist and specialist palliative care. Next, we provided an overview of core ethical principles. We then described key considerations involved in transitioning patients from curative to palliative care in one's own specialty, namely, knowledge, communication, uncertainty, and futility. Finally, we provided an analysis of the introductory case, highlighting the conflict of interest inherent in the transition.
ConclusionsIt is acceptable for neurosurgeons and other specialists with adequate palliative care training to manage the transition to palliative care in most cases, preferably as part of multidisciplinary care teams. While we discuss the example of neurosurgery, this analysis applies to other specialties where care transitions from curative to palliative intent occur. Across specialties, patient preferences and values are foundational in the timing and specifics of this transition.
IntroductionApproximately 22.6 million patients worldwide experience neurological disorders or injuries that necessitate neurosurgical involvement each year, with 13.8 million requiring surgery.1 Although some neurosurgical conditions are curable in certain cases, other cases have no cure and lead to disability, severe physical symptoms, and distress for patients and families. Furthermore, initially curable conditions may progress to become incurable if treatment is not initiated in time or if they become refractory to treatment. Neurosurgeons may be responsible for transitioning management from curative to palliative. However, the associated ethical considerations have not been rigorously analyzed. In this article, we delineate core ethical principles involved in transitioning patients from curative to palliative care and key considerations during this transition. Although we use a neurosurgical example, these arguments can apply to many other specialties that may be involved in the transition from curative to palliative intent (e.g., cardiology, nephrology, oncology, respirology).
Section snippetsMaterials and MethodsThis is a case-based narrative review. We present a neurosurgical case and then describe key ethical considerations.
Neurosurgical Treatment ParadigmsMost often, neurosurgeons perform surgery to minimize morbidity and mortality. Common examples of so-called curative intent are resecting meningiomas, clipping aneurysms, decompressing intracranial pressure in patients with traumatic brain injury, and decompressing spinal levels for patients with myelopathy or radiculopathy secondary to disc herniations. The term palliative is often used variably and improperly in neurosurgery to denote surgeries that are unexpected to eliminate the pathology
ConclusionsNeurosurgeons harness their knowledge, communication strategies, and understanding of uncertainty and futility to provide treatments that are likely to achieve the patient's goals while minimizing unwanted effects. Although neurosurgeons with adequate training in palliative care may be subject to bias while transitioning patients from curative to palliative care, it is generally ethically acceptable for them to manage the transition in most cases, preferably as part of multidisciplinary care
References (58)M.C. Dewan et al.Global neurosurgery: the current capacity and deficit in the provision of essential neurosurgical care. Executive summary of the global neurosurgery initiative at the program in global surgery and social changeJ Neurosurg
(2018)
R.S. Morrison et al.Palliative careN Engl J Med
(2004)
W. Van Mechelen et al.Defining the palliative care patient: a systematic reviewPalliat Med
(2013)
T.E. Quill et al.Generalist plus specialist palliative care—creating a more sustainable modelN Engl J Med
(2013)
L. Forbat et al.Defining ‘specialist palliative care’: findings from a Delphi study of cliniciansAust Health Rev
(2019)
V.S. Periyakoil et al.Generalist versus specialist palliative medicineJ Palliat Med
(2022)
L. Chahine et al.Palliative care needs of patients with neurologic or neurosurgical conditionsEur J Neurol
(2008)
O. Ayling et al.Glioblastoma, the neurosurgeon, and neuro-palliative carePalliat Med Hosp Care Open J
(2015)
J. Weil et al.What’s in a name? A qualitative exploration of what is understood by “palliative care” in the emergency departmentPalliat Med
(2015)
M. Vierhout et al.The views of patients with brain cancer about palliative care: a qualitative studyCurr Oncol
(2017)
K. Brizzi et al.Neuropalliative Care: a Practical Guide for the Neurologist(2018)
C.J. Creutzfeldt et al.Predicting decline and survival in severe acute brain injury: the fourth trajectoryBMJ
(2015)
N.A. Shlobin et al.Neuropalliative care for the neurosurgeon: a primerJ Neurosurg
(2021)
R.G. Holloway et al.Palliative care consultations in hospitalized stroke patientsJ Palliat Med
(2010)
P. Wegier et al.“No thanks, I don’t want to see snakes again”: a qualitative study of pain management versus preservation of cognition in palliative care patientsBMC Palliat Care
(2020)
N.A. Shlobin et al.Informed consent in neurosurgery: a systematic reviewNeurosurg Focus
(2020)
N.A. Shlobin et al.Patient education in neurosurgery: part 1 of a systematic reviewWorld Neurosurg
(2021)
N.A. Shlobin et al.Patient education in neurosurgery: part 2 of a systematic reviewWorld Neurosurg
(2021)
S. Kerrigan et al.Recognition of mental incapacity when consenting patients with intracranial tumours for surgery: how well are we doing?Br J Neurosurg
(2012)
View full text© 2022 Elsevier Inc. All rights reserved.
留言 (0)